Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study-Reference-Cited by-同舟云学术

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study

Published:2014-08-15 Issue:1 Volume:13 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Kaplon-Cieslicka Agnieszka,Postula Marek,Rosiak Marek,Peller Michal,Kondracka Agnieszka,Serafin Agnieszka,Trzepla Ewa,Opolski Grzegorz,Filipiak Krzysztof J

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1186/s12933-014-0112-0/fulltext.html

Reference70 articles.

1. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL: ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013, 34:3035–3087.

2. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71–86.

3. Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G: Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008, 99:14–26.

4. Simpson SH, Abdelmoneim AS, Omran D, Featherstone TR: Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin. Am J Med 2014, 127:95. e1-9.

5. Takahashi S, Ushida M, Komine R, Shimizu A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M: Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thromb Res 2007, 119:517–524.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin for the prevention of pre‐eclampsia in women with pre‐existing diabetes: Systematic review;Australian and New Zealand Journal of Obstetrics and Gynaecology;2021-11-21

2. Resistin is Associated with Inflammation and Renal Function, but not with Insulin Resistance in Type 2 Diabetes;Hormone and Metabolic Research;2021-06-24

3. Determinants of aspirin resistance in patients with type 2 diabetes;Diabetes & Metabolism;2020-10

4. Resistin is a prognostic factor for death in type 2 diabetes;Diabetes/Metabolism Research and Reviews;2018-12-13

5. The Prevalence and Clinical Relevance of ASA Nonresponse After Cardiac Surgery: A Prospective Bicentric Study;Clinical and Applied Thrombosis/Hemostasis;2017-02-23